Document Detail


Effect of enalapril on parasympathetic activity.
MedLine Citation:
PMID:  2285619     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To evaluate the effect of converting enzyme inhibition induced by enalapril on parasympathetic activity, we studied ten essential hypertensive patients, age range 38-58 years, WHO I-II. Parasympathetic evaluation was obtained by measuring the variation of heart period (VHP) during at least 1 minute of steady-state, regular respiration. VHP was derived from the difference between the mean of all maximum and the mean of all minimum heart periods. The higher the VHP, the higher the parasympathetic control of heart rate and vice versa. VHP was measured supine and with tilting (30 degrees, 60 degrees, 85 degrees). Blood pressure was reduced after 1 month of enalapril treatment, while the heart rate did not change. VHP increased at the end of enalapril treatment compared with placebo: in the supine position it increased from 36 +/- 3.2 ms to 44 +/- 3.5 ms, p less than 0.01. VHP was also increased by enalapril at 30 degrees (p less than 0.05) and 60 degrees (p less than 0.05), while no difference was observed at 85 degrees between placebo and enalapril. A positive correlation was found between supine enalapril changes of VHP and those of systolic and diastolic BP. In conclusion, enalapril seems to increase parasympathetic cardiovascular control in essential hypertensive patients. This result might explain the lack of increase in heart rate that would be expected as a result of the vasodilating effect of enalapril.
Authors:
E Boni; C Alicandri; R Fariello; A Zaninelli; A Cantalamessa; L Corda; G Muiesan
Related Documents :
19840529 - The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients...
2303309 - Nicardipine in severe hypertension: oral therapy following intravenous treatment.
6760679 - Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. a...
10078539 - Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studi...
8443029 - Comparison of quinapril and atenolol as single drugs or in combination with hydrochloro...
16222899 - Ventricular and vascular remodelling effects of the angiotensin ii receptor blocker tel...
19944139 - Effects of ear-canal pressurization on middle-ear bone- and air-conduction responses.
17583739 - Stem cells improve right ventricular functional recovery after acute pressure overload ...
15550519 - Reduced oxygen supply explains the negative force-frequency relation and the positive i...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  4     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1991-03-22     Completed Date:  1991-03-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  265-8     Citation Subset:  IM    
Affiliation:
Clinica Medica, University of Brescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Enalapril / pharmacology*
Female
Heart Rate / drug effects
Humans
Hypertension / drug therapy*,  physiopathology
Male
Middle Aged
Parasympathetic Nervous System / drug effects*
Posture
Chemical
Reg. No./Substance:
75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Felodipine in the treatment of patients with severe hypertension and impaired renal function.
Next Document:  Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients.